Change Over Time In The Profile Of Ankylosing Spondylitis Patients Treated With Infliximab In Canadian Routine Care

被引：0
|
作者：
Choquette, Denis [1 ]
Starr, Michael [2 ]
Khraishi, Majed M. [3 ]
Bensen, William G. [4 ,5 ]
Shaikh, Saeed A. [6 ]
Rodrigues, Jude F.
Sholter, Dalton E. [7 ]
Sheriff, Maqbool K. [8 ]
Vaillancourt, Julie [9 ]
Sampalis, John S. [10 ]
Lehman, Allen J. [11 ]
Otawa, Susan M. [11 ]
Nantel, Francois [11 ]
Shawi, May [11 ]
机构：
[1] Inst Rhumatol Montreal, Montreal, PQ, Canada
[2] Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada
[3] Mem Univ Newfoundland, Nexus Clin Res, MD, St John, NF, Canada
[4] St Josephs Hosp, Hamilton, ON, Canada
[5] McMaster Univ, Hamilton, ON, Canada
[6] McMaster Univ, St Catharines, ON, Canada
[7] Rheumatol Associates, Edmonton, AB, Canada
[8] Nanaimo Reg Gen Hosp, Nanaimo, BC, Canada
[9] JSS Med Res, Montreal, PQ, Canada
[10] JSS Med Res, St Laurent, PQ, Canada
[11] Janssen Canada Inc, Toronto, ON, Canada
来源：
ARTHRITIS AND RHEUMATISM | 2013年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2458
引用
收藏
页码：S1051 / S1051
页数：1
相关论文
共 50 条
  • [41] IS THERE CLINICAL VALUE TO ANA MONITORING IN ANKYLOSING SPONDYLITIS PATIENTS TREATED WITH INFLIXIMAB? A RETROSPECTIVE AUDIT OF 70 PATIENTS
    Mathieson, Hannah R.
    Mackie, Sarah L.
    Bryer, Domini
    Buch, Maya
    Emery, Paul
    Marzo-Ortega, Helena
    RHEUMATOLOGY, 2013, 52 : 167 - 167
  • [42] Association of Ankylosing Spondylitis and Crohn's Disease Successfully Treated with Infliximab
    Ana Isabel Castro de Sampaio Rebelo
    Sílvía Leite
    José Cotter
    BioDrugs, 2010, 24 : 37 - 39
  • [43] Association of Ankylosing Spondylitis and Crohn's Disease Successfully Treated with Infliximab
    Rebelo, Ana
    Leite, Silvia
    Cotter, Jose
    BIODRUGS, 2010, 24 : 37 - 39
  • [44] ABSENCE OF RADIOGRAPHIC PROGRESSION OF HIP ARTHRITIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS TREATED WITH INFLIXIMAB FOR 6 YEARS
    Konsta, M.
    Bournia, V. K.
    Sfikakis, P. P.
    Karras, D.
    Iliopoulos, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 249 - 250
  • [45] Predictors of Response in Patients with Ankylosing Spondylitis Treated with Infliximab or Golimumab in a Real-World Setting
    Bessette, Louis
    Kapur, Suneil
    Zummer, Michel
    Starr, Michael
    Choquette, Denis
    Sheriff, Maqbool
    Olszynski, Wojciech
    Rampakakis, Emmanouil
    Psaradellis, Eliofotisti
    Osborne, Brendan
    Maslova, Karina
    Nantel, Francois
    Lehman, Allen
    Tkaczyk, Cathy
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (06) : 1197 - 1197
  • [46] Real-Life Effectiveness of Infliximab in the Treatment of Ankylosing Spondylitis: The Canadian Experience
    Rahinan, Proton
    Sampalis, John
    Khalil, Hayssam
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (06) : 1276 - 1276
  • [47] PREDICTORS OF RESPONSE IN PATIENTS WITH ANKYLOSING SPONDYLITIS TREATED WITH INFLIXIMAB OR GOLIMUMAB IN A REAL-WORLD SETTING
    Bessette, L.
    Kapur, S.
    Zummer, M.
    Starr, M.
    Choquette, D.
    Sheriff, M.
    Olszynski, W.
    Rampakakis, E.
    Psaradellis, E.
    Osborne, B.
    Maslova, K.
    Nantel, F.
    Lehman, A. J.
    Tkaczyk, C. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1131 - 1131
  • [48] Socioeconomic consequences for patients with active ankylosing spondylitis treated for two years with infliximab in a clinical trial
    Brandt, J
    Listing, J
    Krause, A
    Gromnica-Ihle, E
    Kellner, H
    Schneider, M
    Sörensen, H
    Zeidler, H
    Alten, R
    Reddig, J
    Rudwaleit, M
    Sieper, J
    Braun, J
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 256 - 257
  • [49] Ongoing clinical effectiveness and safety of treatment with Infliximab in patients with ankylosing Spondylitis over 6 years
    Baraliakos, X.
    Listing, J.
    Fritz, C.
    Alten, R.
    Burmester, G.
    Krause, A.
    Schewe, S.
    Schneider, S.
    Soerensen, H.
    Zeidler, H.
    Sieper, J.
    Braun, J.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2007, 66 : 51 - 51
  • [50] VALIDATION OF THE ANKYLOSING SPONDYLITIS DISEASE ACTIVITY SCORE (ASDAS) AND EFFECTIVENESS OF INFLIXIMAB IN THE TREATMENT OF ANKYLOSING SPONDYLITIS OVER 4 YEARS
    Rahman, P.
    Choquette, D.
    Khraishi, M.
    Bensen, W.
    Shaikh, S.
    Sholter, D.
    Sheriff, M.
    Rampakakis, E.
    Sampalis, J. S.
    Nantel, F.
    Otawa, S.
    Lehman, A.
    Shawi, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 725 - 725
12345